Comparison of Three Different Chemotherapy Regimens Containing Epirubicin in Hormone-Refractory Prostate Cancer Patients

We compared three different chemotherapy regimens containing epirubicin in hormonerefractory prostate cancer (HRPC) patients. Sixty-nine patients with HRPC were randomized into three groups. The first group (22 patients) received 30 mg/m(2)/week i.v. epirubicin for 8 weeks. The second group (24 pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Ersoy, Hamit, Yigitbası, Orhan, Sagnak, Levent, Topaloglu, Hikmet, Kiper, Ahmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: TheScientificWorldJOURNAL 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848728/
https://www.ncbi.nlm.nih.gov/pubmed/18604442
http://dx.doi.org/10.1100/tsw.2008.90

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848728/
https://www.ncbi.nlm.nih.gov/pubmed/18604442
http://dx.doi.org/10.1100/tsw.2008.90

Ejemplares similares